IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-κB activation (original) (raw)

• Eissner, G., Kolch, W. & Scheurich, P. Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. Cytokine Growth Factor Rev. 15, 353–366 (2004).
  CAS PubMed Google Scholar
• Grohmann, U. et al. CTLA-4–Ig regulates tryptophan catabolism in vivo. Nature Immunol. 3, 1097–1101 (2002).
  CAS Google Scholar
• Mellor, A. L. et al. Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J. Immunol. 171, 1652–1655 (2003).
  CAS PubMed Google Scholar
• Orabona, C. et al. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nature Immunol. 5, 1134–1142 (2004).
  CAS Google Scholar
• Munn, D. H., Sharma, M. D. & Mellor, A. L. Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J. Immunol. 172, 4100–4110 (2004).
  CAS PubMed Google Scholar
• Grohmann, U., Fallarino, F. & Puccetti, P. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol. 24, 242–248 (2003).
  CAS PubMed Google Scholar
• Taylor, M. W. & Feng, G. S. Relationship between interferon-γ, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 5, 2516–2522 (1991).
  CAS PubMed Google Scholar
• Du, M. X., Sotero-Esteva, W. D. & Taylor, M. W. Analysis of transcription factors regulating induction of indoleamine 2,3-dioxygenase by IFN-γ. J. Interferon Cytokine Res. 20, 133–142 (2000).
  CAS PubMed Google Scholar
• Munn, D. H. et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297, 1867–1870 (2002).
  CAS PubMed Google Scholar
• Romani, L. & Puccetti, P. Protective tolerance to fungi: the role of IL-10 and tryptophan catabolism. Trends Microbiol. 14, 183–189 (2006).
  CAS PubMed Google Scholar
• Gilliet, M. & Liu, Y. J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195, 695–704 (2002).
  CAS PubMed PubMed Central Google Scholar
• Moseman, E. A. et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J. Immunol. 173, 4433–4442 (2004).
  CAS PubMed Google Scholar
• Bluestone, J. A. & Tang, Q. How do CD4+CD25+ regulatory T cells control autoimmunity? Curr. Opin. Immunol. 17, 638–642 (2005).
  CAS PubMed Google Scholar
• Ito, T. et al. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 204, 105–115 (2007).
  CAS PubMed PubMed Central Google Scholar
• Finger, E. B. & Bluestone, J. A. When ligand becomes receptor—tolerance via B7 signaling on DCs. Nature Immunol. 3, 1056–1057 (2002).
  CAS Google Scholar
• Fallarino, F. et al. Modulation of tryptophan catabolism by regulatory T cells. Nature Immunol. 4, 1206–1212 (2003).
  CAS Google Scholar
• Mellor, A. L. & Munn, D. H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nature Rev. Immunol. 4, 762–774 (2004).
  CAS Google Scholar
• Munn, D. H. et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281, 1191–1193 (1998).
  CAS PubMed Google Scholar
• Aluvihare, V. R., Kallikourdis, M. & Betz, A. G. Regulatory T cells mediate maternal tolerance to the fetus. Nature Immunol. 5, 266–271 (2004).
  CAS Google Scholar
• Mellor, A. L. & Munn, D. H. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol. Today 20, 469–473 (1999).
  CAS PubMed Google Scholar
• Uyttenhove, C. et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nature Med. 9, 1269–1274 (2003).
  CAS PubMed Google Scholar
• Seo, S. K. et al. 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nature Med. 10, 1088–1094 (2004).
  CAS PubMed Google Scholar
• Muller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E. & Prendergast, G. C. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nature Med. 11, 312–319 (2005).
  CAS PubMed Google Scholar
• Platten, M. et al. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 310, 850–855 (2005).
  CAS PubMed Google Scholar
• Boasso, A. et al. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 109, 3351–3359 (2007).
  CAS PubMed PubMed Central Google Scholar
• Hayden, M. S. & Ghosh, S. Signaling to NF-κB. Genes Dev. 18, 2195–2224 (2004).
  CAS PubMed Google Scholar
• Bonizzi, G. & Karin, M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280–288 (2004).
  CAS PubMed Google Scholar
• Lawrence, T., Bebien, M., Liu, G. Y., Nizet, V. & Karin, M. IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 434, 1138–1143 (2005).
  CAS PubMed Google Scholar
• Kinoshita, D. et al. Essential role of IκB kinase α in thymic organogenesis required for the establishment of self-tolerance. J. Immunol. 176, 3995–4002 (2006).
  CAS PubMed Google Scholar
• Grohmann, U. et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nature Med. 13, 579–586 (2007).
  CAS PubMed Google Scholar
• Bonizzi, G. et al. Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers. EMBO J. 23, 4202–4210 (2004).
  CAS PubMed PubMed Central Google Scholar
• Ball, H. J. et al. Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene 396, 203–213 (2007).
  CAS PubMed Google Scholar
• Asselin-Paturel, C. et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nature Immunol. 2, 1144–1150 (2001).
  CAS Google Scholar
• Colonna, M., Trinchieri, G. & Liu, Y. J. Plasmacytoid dendritic cells in immunity. Nature Immunol. 5, 1219–1226 (2004).
  CAS Google Scholar
• Trinchieri, G. & Sher, A. Cooperation of Toll-like receptor signals in innate immune defence. Nature Rev. Immunol. 7, 179–190 (2007).
  CAS Google Scholar
• Wood, K. J. & Sawitzki, B. Interferon γ: a crucial role in the function of induced regulatory T cells in vivo. Trends Immunol. 27, 183–187 (2006).
  CAS PubMed Google Scholar
• Hayashi, T. et al. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J. Clin. Invest. 114, 270–279 (2004).
  CAS PubMed PubMed Central Google Scholar
• Fallarino, F. et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells. J. Immunol. 176, 6752–6761 (2006).
  CAS PubMed Google Scholar
• Yang, C. H., Murti, A. & Pfeffer, L. M. Interferon induces NF-κB-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-κB activation to promote cell survival. J. Biol. Chem. 280, 31530–31536 (2005).
  CAS PubMed Google Scholar
• Fallarino, F. et al. Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. Int. Immunol. 17, 1429–1438 (2005).
  CAS PubMed Google Scholar
• Tang, Q. & Bluestone, J. A. Plasmacytoid DCs and Treg cells: casual acquaintance or monogamous relationship? Nature Immunol. 7, 551–553 (2006).
  CAS Google Scholar
• Munn, D. H. et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22, 633–642 (2005).
  CAS PubMed Google Scholar
• Manlapat, A. K., Kahler, D. J., Chandler, P. R., Munn, D. H. & Mellor, A. L. Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells. Eur. J. Immunol. 37, 1064–1071 (2007).
  CAS PubMed Google Scholar
• Puccetti, P. On watching the watchers: IDO and type I/II IFN. Eur. J. Immunol. 37, 876–879 (2007).
  CAS PubMed Google Scholar
• Medzhitov, R. Toll-like receptors and innate immunity. Nature Rev. Immunol. 1, 135–145 (2001).
  CAS Google Scholar
• Hoebe, K. et al. Genetic analysis of innate immunity. Adv. Immunol. 91, 175–226 (2006).
  CAS PubMed Google Scholar
• Braun, D., Longman, R. S. & Albert, M. L. A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood 106, 2375–2381 (2005).
  CAS PubMed PubMed Central Google Scholar
• Orabona, C. et al. Towards the identification of a tolerogenic signature in IDO-competent dendritic cells. Blood 107, 2846–2854 (2006).
  CAS PubMed Google Scholar
• Hoshino, K. et al. IκB kinase-α is critical for interferon-α production induced by Toll-like receptors 7 and 9. Nature 440, 949–953 (2006).
  CAS PubMed Google Scholar
• Mellor, A. L. et al. Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN type 1 signaling. J. Immunol. 175, 5601–5605 (2005).
  CAS PubMed Google Scholar
• Wingender, G. et al. Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO. Eur. J. Immunol. 36, 12–20 (2006).
  CAS PubMed Google Scholar
• Christensen, S. R. et al. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25, 417–428 (2006).
  CAS PubMed Google Scholar
• Lomada, D., Liu, B., Coghlan, L., Hu, Y. & Richie, E. R. Thymus medulla formation and central tolerance are restored in IKKα−/− mice that express an IKKα transgene in keratin 5+ thymic epithelial cells. J. Immunol. 178, 829–837 (2007).
  CAS PubMed Google Scholar
• Lu, L. F., Gondek, D. C., Scott, Z. A. & Noelle, R. J. NFκB-inducing kinase deficiency results in the development of a subset of regulatory T cells, which shows a hyperproliferative activity upon glucocorticoid-induced TNF receptor family-related gene stimulation. J. Immunol. 175, 1651–1657 (2005).
  CAS PubMed Google Scholar
• Curti, A. et al. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25− into CD25+ T regulatory cells. Blood 109, 2871–2877 (2007).
  CAS PubMed Google Scholar
• Hwu, P. et al. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J. Immunol. 164, 3596–3599 (2000).
  CAS PubMed Google Scholar
• Grohmann, U. et al. Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. J. Immunol. 171, 2581–2587 (2003).
  CAS PubMed Google Scholar
• Vacca, C. et al. CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig. Microbes Infect. 7, 1040–1048 (2005).
  CAS PubMed Google Scholar
• Tas, S. W. et al. Non-canonical NF-κB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation. Blood 4 May 2007 (doi:10.1182/blood-2006-11-056010).
  CAS PubMed Google Scholar
• Ochando, J. C. et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nature Immunol. 7, 652–662 (2006).
  CAS Google Scholar
• Romani, L. et al. Thymosin α1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. Blood 108, 2265–2274 (2006).
  CAS PubMed Google Scholar
• Fallarino, F. & Puccetti, P. Toll-like receptor 9-mediated induction of the immunosuppressive pathway of tryptophan catabolism. Eur. J. Immunol. 36, 8–11 (2006).
  CAS PubMed Google Scholar
• Fallarino, F. et al. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J. Immunol. 173, 3748–3754 (2004).
  CAS PubMed Google Scholar
• Belladonna, M. L. et al. Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. J. Immunol. 177, 130–137 (2006).
  CAS PubMed Google Scholar
• Grohmann, U. et al. A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J. Exp. Med. 198, 153–160 (2003).
  CAS PubMed PubMed Central Google Scholar
• Munn, D. H. et al. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J. Clin. Invest. 114, 280–290 (2004).
  CAS PubMed PubMed Central Google Scholar
• Munn, D. H. Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation. Curr. Opin. Immunol. 18, 220–225 (2006).
  CAS PubMed Google Scholar
• Gurtner, G. J., Newberry, R. D., Schloemann, S. R., McDonald, K. G. & Stenson, W. F. Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice. Gastroenterology 125, 1762–1773 (2003).
  CAS PubMed Google Scholar
• Santucci, L. et al. GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice. Gut 56, 52–60 (2007).
  CAS PubMed Google Scholar
• Wills-Karp, M., Santeliz, J. & Karp, C. L. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nature Rev. Immunol. 1, 69–75 (2001).
  CAS Google Scholar
• Bach, J. F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347, 911–920 (2002).
  PubMed Google Scholar
• Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S. & Medzhitov, R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118, 229–241 (2004).
  CAS PubMed Google Scholar
• Neish, A. S. et al. Prokaryotic regulation of epithelial responses by inhibition of IκB-α ubiquitination. Science 289, 1560–1563 (2000).
  CAS PubMed Google Scholar
• Kelly, D. et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA. Nature Immunol. 5, 104–112 (2004).
  CAS Google Scholar
• Foligne, B. et al. A key role of dendritic cells in probiotic functionality. PLoS ONE 2, e313–e324 (2007).
  PubMed PubMed Central Google Scholar
• Elias, J. A., Zhu, Z., Chupp, G. & Homer, R. J. Airway remodeling in asthma. J. Clin. Invest. 104, 1001–1006 (1999).
  CAS PubMed PubMed Central Google Scholar
• Padrid, P. A. et al. CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma. Am. J. Respir. Cell Mol. Biol. 18, 453–462 (1998).
  CAS PubMed Google Scholar
• Montagnoli, C. et al. Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J. Immunol. 176, 1712–1723 (2006).
  CAS PubMed Google Scholar
• Hayashi, T. & Raz, E. TLR9-based immunotherapy for allergic disease. Am. J. Med. 119, 897.e1–897.e6 (2006).
  Google Scholar
• De Bosscher, K., Vanden Berghe, W. & Haegeman, G. The interplay between the glucocorticoid receptor and nuclear factor-κB or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev. 24, 488–522 (2003).
  CAS PubMed Google Scholar
• Karagiannidis, C. et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J. Allergy Clin. Immunol. 114, 1425–1433 (2004).
  CAS PubMed Google Scholar
• Turck, J., Oberdorfer, C., Vogel, T., Mackenzie, C. R. & Daubener, W. Enhancement of antimicrobial effects by glucocorticoids. Med. Microbiol. Immunol. 194, 47–53 (2005).
  PubMed Google Scholar
• Tang, Q. et al. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J. Immunol. 171, 3348–3352 (2003).
  CAS PubMed Google Scholar
• Orabona, C. et al. Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12. Eur. J. Immunol. 35, 3111–3118 (2005).
  CAS PubMed Google Scholar
• Orabona, C. et al. Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. J. Immunol. 174, 6582–6586 (2005).
  CAS PubMed Google Scholar
• Blasius, A. L. & Colonna, M. Sampling and signaling in plasmacytoid dendritic cells: the potential roles of Siglec-H. Trends Immunol. 27, 255–260 (2006).
  CAS PubMed Google Scholar
• Fallarino, F. et al. Functional expression of indoleamine 2,3-dioxygenase by murine CD8α+ dendritic cells. Int. Immunol. 14, 65–68 (2002).
  CAS PubMed Google Scholar
• Fallarino, F. et al. T cell apoptosis by tryptophan catabolism. Cell. Death Differ. 9, 1069–1077 (2002).
  CAS PubMed Google Scholar
• Terness, P. et al. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196, 447–457 (2002).
  CAS PubMed PubMed Central Google Scholar
• Frumento, G. et al. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med. 196, 459–468 (2002).
  CAS PubMed PubMed Central Google Scholar
• Sawitzki, B. et al. IFN-γ production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J. Exp. Med. 201, 1925–1935 (2005).
  CAS PubMed PubMed Central Google Scholar
• Zegarra-Moran, O. et al. Double mechanism for apical tryptophan depletion in polarized human bronchial epithelium. J. Immunol. 173, 542–549 (2004).
  CAS PubMed Google Scholar
• Beutelspacher, S. C. et al. Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses. Am. J. Transplant. 6, 1320–1330 (2006).
  CAS PubMed Google Scholar
• Grohmann, U. et al. IL-6 inhibits the tolerogenic function of CD8α+ dendritic cells expressing indoleamine 2,3-dioxygenase. J. Immunol. 167, 708–714 (2001).
  CAS PubMed Google Scholar
• Zaph, C. et al. Epithelial-cell-intrinsic IKK-β expression regulates intestinal immune homeostasis. Nature 446, 552–556 (2007).
  CAS PubMed Google Scholar